These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21083141)

  • 1. Metabolite quantitation: detector technology and MIST implications.
    Wright P; Miao Z; Shilliday B
    Bioanalysis; 2009 Jul; 1(4):831-45. PubMed ID: 21083141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites in safety testing: metabolite identification strategies in discovery and development.
    Nedderman AN
    Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
    Deng Y; Wu JT; Zhang H; Olah TV
    Rapid Commun Mass Spectrom; 2004; 18(15):1681-5. PubMed ID: 15282765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.
    Leclercq L; Cuyckens F; Mannens GS; de Vries R; Timmerman P; Evans DC
    Chem Res Toxicol; 2009 Feb; 22(2):280-93. PubMed ID: 19183054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR spectroscopy as a tool to close the gap on metabolite characterization under MIST.
    Caceres-Cortes J; Reily MD
    Bioanalysis; 2010 Jul; 2(7):1263-76. PubMed ID: 21083239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A holistic strategy for characterizing the safety of metabolites through drug discovery and development.
    Walker D; Brady J; Dalvie D; Davis J; Dowty M; Duncan JN; Nedderman A; Obach RS; Wright P
    Chem Res Toxicol; 2009 Oct; 22(10):1653-62. PubMed ID: 19715349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations.
    Zhu M; Zhang D; Zhang H; Shyu WC
    Biopharm Drug Dispos; 2009 May; 30(4):163-84. PubMed ID: 19544287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the "Metabolites in Safety Testing" Regulatory Guidance.
    Schadt S; Bister B; Chowdhury SK; Funk C; Hop CECA; Humphreys WG; Igarashi F; James AD; Kagan M; Khojasteh SC; Nedderman ANR; Prakash C; Runge F; Scheible H; Spracklin DK; Swart P; Tse S; Yuan J; Obach RS
    Drug Metab Dispos; 2018 Jun; 46(6):865-878. PubMed ID: 29487142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of evaporative light-scattering detection for metabolite quantification without authentic analytical standards or radiolabel.
    Fries HE; Evans CA; Ward KW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):339-44. PubMed ID: 15833299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalytical method validation: notable points in the 2009 draft EMA Guideline and differences with the 2001 FDA Guidance.
    Smith G
    Bioanalysis; 2010 May; 2(5):929-35. PubMed ID: 21083222
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of experimental design in the development of an HPLC-ECD method for the analysis of captopril.
    Khamanga SM; Walker RB
    Talanta; 2011 Jan; 83(3):1037-49. PubMed ID: 21147355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and solutions to metabolites in safety testing: impact of the International Conference on Harmonization M3(R2) guidance.
    Yu H; Bischoff D; Tweedie D
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1539-49. PubMed ID: 21067462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of metabolite safety testing from an industry perspective.
    Anderson S; Knadler MP; Luffer-Atlas D
    Bioanalysis; 2010 Jul; 2(7):1249-61. PubMed ID: 21083238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From definition to implementation: a cross-industry perspective of past, current and future MIST strategies.
    Nedderman AN; Dear GJ; North S; Obach RS; Higton D
    Xenobiotica; 2011 Aug; 41(8):605-22. PubMed ID: 21446837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches for the rapid identification of drug metabolites in early clinical studies.
    Dear GJ; Beaumont C; Roberts A; Squillaci B; Thomas S; Nash M; Fraser D
    Bioanalysis; 2011 Jan; 3(2):197-213. PubMed ID: 21250848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the bioanalytical community ready to revise the use of certain validation concepts and nomenclature?
    Olsson AO; Liljeblad M; Nilsson LB; Silvester S
    Bioanalysis; 2012 Jul; 4(14):1705-8. PubMed ID: 22877214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.